IP Library › Granted Patent US 7,576,071
Granted Patent B2
US 7,576,071 · App. 11/468,988 · Granted Aug 18, 2009

Antithrombotic compound

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,576,071
App. No.
11/468,988
Granted
Aug 18, 2009
Kind
B2
Abstract

The present invention relates compounds of the formula A oligosaccharide-spacer-GpIIb/IIIa antagonist   (A). The compounds of the invention have antithrombotic activity and can be used in treating or preventing thrombotic diseases.

Claims (7)

1. A compound of the formula A

oligosaccharide-spacer-GpIIb/IIIa antagonist   (A),

wherein the compound is selected from the following compounds:

and

2. A pharmaceutical composition comprising a compound of claim 1 and pharmaceutically suitable auxiliaries.

3. A method of treating a thrombotic disorder, comprising: administering to a patient in need thereof a therapeutically effective amount of a compound according to claim 1 .

4. The method of claim 3 , wherein the thrombotic disorder is selected from: acute myocardial infarction, ischemia and stroke.

Assignments (2)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2006
From: BUIJSMAN, ROGIER CHRISTIAN; DE KORT, MARTIN; MEULEMAN, DIRK GERRIT; VAN BOECKEL, CONSTANT
To: SANOFI-AVENTIS
Reel/Frame 018566/0775 →